| Lumify (U.S.N.L.M.) | ||
|---|---|---|
| Dosing | Instill 1 drop in the affected eye(s) every 6-8 hours. | |
| Chem Specs | brimonidine tartrate (0.025%) | |
| Quantities | 2.5, 7.5ml | |
| Cost | 15.00/2.5ml | |
| Class | adrenergic receptor agonist (primarily alpha-2) | |
| Action | Selectively constricts venules. | |
| Usage | OTC eye whitener. | |
| Side Effects | At higher concentrations brimonidine is known to cause 10–20% rate of allergic conjunctivitis, conjunctival hyperemia, oral dryness, foreign body sensation. |
|
| Contraindications | Hypersensitivity to brimonidine or any other ingredient in the product. | |
| Pediatric use | Children 5 years of age and over | |
| Pregnancy | Category B (Alphagan) No teratogenicity in rats at 360 times the normal human dosage. | |
| BAK preserved. | ||
| Wait at least 10 minutes before re-inserting contact lenses after use. Usage can mask the progression of underlying pathology. |
||